Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Young Joo Cha
Prolonged Entecavir Therapy Is Not Effective for HBeAg Seroconversion in Treatment-Naive Chronic Hepatitis B Patients With a Partial Virological Response
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Proposal of Modified HIL-indices for Determining Hemolysis, Icterus and Lipemia Interference on the Beckman Coulter AU5800 Automated Platform
Laboratory Medicine Online
Related publications
Association of Virological Breakthrough and Clinical Outcomes in Entecavir-Treated HBeAg-positive Chronic Hepatitis B
PLoS ONE
Multidisciplinary
Editorial: Identifying Candidates for Pegylated Interferon Add-On to Entecavir Therapy in Patients With HBeAg-positive Chronic Hepatitis B
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: HBeAg Seroconversion Is Not Sufficient to Allow Cessation of Nucleos(t)ide Analogue Treatment in Caucasian Hepatitis B Patients
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Identifying Candidates for Pegylated Interferon Add-On to Entecavir Therapy in Patients With HBeAg-positive Chronic Hepatitis B - Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Upgrade Combination Response Is Limited by Prolonged Nucelos(t)ide Analogue Therapy in HBeAg-positive Chronic Hepatitis B: A Real-Life Study
Journal of Clinical and Translational Hepatology
An Open Label Prospective Study to Evaluate the Efficacy of Entecavir in HBeAg Positive Treatment Naive Chronic Hepatitis –B Patients in a Tertiary Care Centre in Eastern India
Journal of Medical Science And clinical Research
Changes of Serum sPD-1 Levels in HBeAg-positive Chronic Hepatitis B Patients With Entecavir Treatment and Correlation With Curative E Ect
Turkish Journal of Medical Sciences
Medicine
Bushenjianpi Formula Combined With Entecavir for HBeAg-negative Chronic Hepatitis B Patients: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet
Medicine
Virological Response to Treatment With Peginterferon Alfa-2a in Adolescents With Chronic Hepatitis B.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
